Three two-site apoA-I immunoassays using phage expressed detector antibodies – Preliminary clinical evaluation with cardiac patients-Reference-Cited by-同舟云学术

Three two-site apoA-I immunoassays using phage expressed detector antibodies – Preliminary clinical evaluation with cardiac patients

Published:2021-02 Issue: Volume:194 Page:113772
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Negi Priyanka,Heikkilä Taina,Tallgren Terhi,Malmi Päivi,Lund Juha,Sinisalo Juha,Metso Jari,Jauhiainen Matti,Pettersson Kim,Lamminmäki Urpo,Lövgren Janita

Funder

Finnish Funding Agency for Technology and Innovation

University of Turku Graduate School

Academy of Finland

Finnish Foundation for Cardiovascular Research

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference35 articles.

1. The metabolism and anti-atherogenic properties of HDL;Rye;J. Lipid Res.,2009

2. Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors;Barter;Atheroscler,2002

3. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study;Gordon;Am. J. Med.,1977

4. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events;Barter;N. Engl. J. Med.,2007

5. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis;Briel;BMJ,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease;Frontiers in Cardiovascular Medicine;2022-10-14